Abbott India informs about appointment of senior management personnel

12 Apr 2024 Evaluate

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Abbott India has informed that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the appointment of Murari Ranganathan as Commercial Director - Women’s Health, Metabolics and International Business effective May 2, 2024. He will be part of the Senior Management team of the Company. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 is enclosed as Annexure A. 

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

28871.70 255.30 (0.89%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×